🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to LSX Congress USA — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds
About this event
LSX Congress USA (LSX World Congress USA)
LSX Congress USA is an in-person executive conference designed for senior biotech leadership, bringing together North America’s leading Biotech CEOs for a focused, high-level two-day program. The event combines executive-only conference sessions with in-person 1-2-1 partnering and company showcasing opportunities, creating an environment built for strategic discussion, peer-to-peer networking, and partner discovery.
Dates
- Forums: September 22, 2026
- Congress: September 23–24, 2026
Venue & Location
The congress is hosted at the Hynes Convention Center in Boston, Massachusetts, USA.
Event type & format
LSX World Congress USA is structured as a senior leadership executive conference with an integrated partnering component. The program is delivered in three main layers:
- 2-day executive conference: Senior biotech CEOs participate in high-level sessions focused on leadership, strategy, and sector-relevant themes.
- In-person 1-2-1 partnering: Designed to facilitate direct meetings between attendees, supporting deal-making, collaboration exploration, and relationship building.
- Company showcasing opportunities: Provides selected organizations with a platform to highlight their work and partnership potential within the same connected experience.
Who it’s for (attendees/buyer audience)
This event is positioned around a “high-quality senior audience” model. Attendees include:
- Biotech CEOs from the network in North America as the core executive group
- Investors and investment decision-makers from sectors most active in biotech funding and deal activity
- Big pharma leaders and commercial leaders engaged in partnerships, collaborations, and innovation pipelines
- Trusted advisors who provide subject-matter depth and senior peer discussion
Key themes & why attendees participate
LSX Congress USA focuses on facilitating senior-level connections across the biotech ecosystem. The event aims to bring together leaders who are actively involved in innovation, investment, and commercialization, enabling structured discussions and direct partnering opportunities. Attendees are brought to the same venue and time window to create continuity from executive sessions through to in-person 1-2-1 meetings.
Partnering, networking, and senior engagement
The positioning of LSX World Congress USA emphasizes getting out of traditional work routines and engaging in meaningful peer-to-peer conversation and high-level networking. Because the event includes an in-person 1-2-1 partnering component, the networking is designed to be outcome-oriented—supporting partner discovery and strengthening relationships between executives, investors, and senior industry leaders.
What’s changing / event relationship note
The event page states that BioPharm America is merging with LSX USA. As part of this combination, BioPharm America will merge with LSX World Congress USA, creating a single larger, cohesive experience. The merged event is intended to provide additional opportunities to find the right partners and investors via one streamlined format.
Past speaker examples (signals of audience seniority)
The event page lists past speakers that illustrate the senior and cross-sector nature of the audience, including leadership from organizations such as:
- Inceptor Bio (CEO)
- North Carolina Department of Commerce (Secretary of Commerce)
- NCBiotech (Director of Investments)
- Johnson & Johnson Innovation (Head, Johnson & Johnson Innovation, East North America)
- Locus Biosciences (CFO)
- OmniAb, Inc. (Sr. Vice President, Ion Channels/Transporters)
- UNC-Chapel Hill (Director of Industry Engagement)
- Parexel (Vice President, Cell and Gene Therapy)
Quick summary
LSX Congress USA (LSX World Congress USA) is a senior executive biotech conference held in Boston, USA at the Hynes Convention Center on September 23–24, 2026, with Forums on September 22, 2026. It blends a 2-day executive agenda with in-person 1-2-1 partnering and company showcasing, designed to connect biotech CEOs with investors, big pharma and commercial leaders, and trusted advisors in a high-impact, face-to-face environment.
Data sheet
LSX Congress USA – Event Attendee & Buyer Profile Analysis
Event Date: September 23–24, 2026
Location: Boston, MA, United States
Event Status: Upcoming
Research Date: July 2, 2026
Event Overview
| Event Name | LSX Congress USA |
|---|---|
| Event Date | September 23–24, 2026; forums on September 22, 2026 |
| Event Status | Upcoming |
| Venue | Hynes Convention Center |
| City | Boston |
| State / Region | Massachusetts |
| Country | United States |
| Organizer | Informa Connect / EBD Group and LSX |
| Official Event Website | informaconnect.com/biopharm-america/ |
| Event Type | Life sciences partnering conference, executive networking, and company showcasing event |
| Primary Category | Medical & Pharma |
| Secondary Applicable Categories | Science & Research; Business Services; Biotechnology; IT & Technology |
| Audience Reach | National with international participation |
| Estimated Attendance / Expected Footfall | Attendance figure not publicly confirmed by the organizer. |
| Attendance Data Reliability | Medium. The organizer confirms a senior audience and 2-day executive format, but no public current-year headcount is provided in the source text. |
| Main Purpose of Event | To connect biotech CEOs, investors, big pharma leaders, commercial leaders, and trusted advisors for partnering, networking, company showcasing, and business development |
About the Event
| LSX Congress USA is a senior-level life sciences partnering event positioned around biotech business development, investor engagement, and strategic collaboration. The official site indicates that BioPharm America is merging with LSX World Congress USA, creating a larger, cohesive experience centered on North America’s leading biotech CEOs, active investors, big pharma stakeholders, and commercial leaders. |
| The event matters because it concentrates decision-makers involved in fundraising, partnering, licensing, commercialization, and innovation scouting. For suppliers and service providers, this is a strong environment for lead generation, account targeting, strategic introductions, and relationship-building with organizations that influence R&D partnerships, clinical development, business development, and corporate growth in the biotech and pharma ecosystem. |
1. Who Attends: Buyers / Attendees
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Biotech CEOs and Founders | Emerging and mid-stage biotech companies | Strategic decision-makers for partnering, outsourcing, and vendor selection | High-value targets for solution providers in clinical development, data, consulting, and commercialization |
| Business Development Leaders | Biotech, pharma, medtech, and platform companies | Lead licensing, alliances, and partner sourcing | Highly relevant for partnership platforms, advisory services, CROs, and investor-intro solutions |
| Investors / VC / Growth Equity | Life sciences venture funds, corporate venture teams | Influence funding, portfolio support, and market access | Relevant for deal flow tools, market intelligence, diligence, and ecosystem services |
| Big Pharma Commercial Leaders | Large pharmaceutical companies | Influence collaboration, licensing, and pipeline expansion | Relevant for vendors supporting commercialization, analytics, and innovation scouting |
| R&D / Innovation Leaders | Biotech, pharma, research institutions | Evaluate science, platforms, and external innovation | Relevant for lab services, research tools, scientific software, and discovery platforms |
| Commercial / Market Access Leaders | Pharma and biotech commercial teams | Influence launch planning, access strategy, and partner ecosystems | Relevant for market access, pricing, analytics, and patient engagement providers |
| Advisors / Consultants | Life sciences advisory firms, law firms, strategy consultants | Advise on deals, regulation, strategy, and corporate development | Relevant for legal, consulting, and outsourced specialist services |
| Academic and Translational Leaders | Universities, medical schools, tech transfer offices | Influence licensing, spinouts, and collaboration pipelines | Relevant for technology transfer, research services, and innovation brokers |
2. Event Location and Attendee Geographic Origin
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Host city: Boston | High local attendance from Boston/Cambridge life sciences cluster | Very high | Boston is a major biotech and pharma hub, making it a strong draw for CEOs, BD teams, investors, and service providers |
| Host region: Massachusetts / New England | Regional attendance from Greater Boston, Cambridge, Worcester, Providence, and surrounding states | High | Dense concentration of biotech, universities, hospitals, and venture capital |
| Nearby business hubs | New York, New Jersey, Philadelphia, Raleigh-Durham, and Washington, DC area participants | High | These corridors contain pharma HQs, biotech clusters, investors, and legal/advisory firms |
| National reach | US-wide attendance from biotech, pharma, CRO, CDMO, and investor communities | Very high | The event format is aligned with national business development and partnering agendas |
| International reach | Likely participation from global pharma, investors, and advisors | Moderate to high | The official page references world-class senior audiences and global partnering relevance |
3. Audience Reach
| Reach Level | Assessment | Explanation |
|---|---|---|
| Global | Primary classification: Global | The event is positioned for senior biotech, investor, and pharma audiences with partnering relevance across North America and international life sciences markets. |
4. Sample Buyer Companies and Websites
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| Inceptor Bio | Biotech company | Listed among past speakers on the official event page; relevant to partnering and executive biotech audiences | inceptorbio.com | CEO, Founder, Business Development, Corporate Development | Confirmed Speaker Organization |
| North Carolina Department of Commerce | Government / economic development | Officially named on the event page as a past speaker organization; relevant to state biotech ecosystem development | commerce.nc.gov | Secretary, Director, Life Sciences Economic Development | Confirmed Speaker Organization |
| NCBiotech | Biotech ecosystem organization | Listed as a past speaker organization; relevant to industry network building and cluster development | ncbiotech.org | Director of Investments, Partnerships, Ecosystem Development | Confirmed Speaker Organization |
| Johnson & Johnson Innovation | Corporate innovation / pharma | Officially listed as a past speaker organization; a strong fit for licensing, scouting, and partnering | jnj.com/innovation | Head of Innovation, External Innovation, BD&L | Confirmed Speaker Organization |
| Locus Biosciences | Biotech company | Officially listed as a past speaker organization; relevant to biotech executive networking and service buying | locusbio.com | CFO, CEO, Business Development | Confirmed Speaker Organization |
| OmniAb, Inc. | Biotech platform company | Officially listed as a past speaker organization; relevant to platform technology, partnering, and commercialization | omniab.com | SVP, Business Development, Product Strategy | Confirmed Speaker Organization |
| UNC-Chapel Hill | Academic / research institution | Officially listed as a past speaker organization; relevant to technology transfer and translational research | unc.edu | Director of Industry Engagement, Tech Transfer, Research Partnerships | Confirmed Speaker Organization |
| Parexel | CRO / life sciences services | Officially listed as a past speaker organization; relevant to clinical development and outsourcing services | parexel.com | VP Clinical Operations, Business Development, Program Manager | Confirmed Speaker Organization |
| Johnson & Johnson | Pharma / healthcare | Referenced through J&J Innovation leadership in the official event content; strong pharma partnering relevance | jnj.com | Head of Innovation, BD&L, Alliance Management | Confirmed Speaker Organization |
| BioPharm America / LSX Network | Organizer / life sciences networking platform | The official page states BioPharm America is merging with LSX World Congress USA; key ecosystem organizer context | informaconnect.com/biopharm-america/ | Partnerships, Delegate Sales, Event Sponsorship | Confirmed Government / Procurement Organization |
| Informa Connect | Organizer / events company | Official site owner and event operator; important for sponsorship, delegate services, and audience analysis | informaconnect.com | Event Director, Partnership Manager, Sales Director | Confirmed Sponsor / Exhibitor |
| Big pharma sponsors and partners | Pharma / corporate partner | The official page states big pharma leaders are part of the senior audience; many are likely buyer-side attendees | varies | Corporate Development, External Innovation, Alliance Management | Prior-Year Participation Evidence |
5. Job Profiles, Industries and Event Type
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Chief Executive Officer / Founder | Executive Office | C-Level | Primary decision-maker for partnerships, fundraising, and strategic vendor selection |
| 2 | Chief Business Officer / VP Business Development | Business Development | VP / C-Level | Owns partnering, licensing, and deal-making conversations at the event |
| 3 | Corporate Development Director | Corporate Development | Director | Evaluates collaborations, acquisitions, and strategic alliances |
| 4 | Head of Innovation / External Innovation | Innovation | Director / VP | Looks for new technologies, platforms, and partners |
| 5 | Investor / Principal / Partner | Investment | Principal / Partner | Influences financing and portfolio-company support |
| 6 | Head of Alliance Management | Alliance Management | Director / VP | Manages strategic partnerships and commercialization relationships |
| 7 | VP Clinical Development / Clinical Operations | Clinical Development | VP / Director | Relevant for CROs, site services, tech platforms, and operational vendors |
| 8 | Director of Industry Engagement / Tech Transfer | Academic Partnerships | Director | Represents university commercialization and collaboration pipelines |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Biotechnology | Core audience for biotech CEOs, partnering, innovation, and fundraising | Target biotech founders, BD leaders, and platform companies |
| 2 | Pharmaceuticals | Big pharma commercial and innovation leaders are explicitly referenced by the organizer | Target licensing, alliance, and innovation executives |
| 3 | Medical Devices | Adjacent life sciences buyers may attend for strategic partnering and commercialization | Target innovation and business development leaders |
| 4 | Hospital & Health Care | Relevant for translational research, clinical partnerships, and healthcare innovation | Target research collaborations and provider innovation teams |
| 5 | Research | Fits academic, translational, and R&D participant groups | Target research directors and scientific partnership teams |
| 6 | Venture Capital & Private Equity | Investors are explicitly named in the official event description | Target investors, principals, and life sciences partners |
| 7 | Management Consulting | Advisors and strategy consultants are part of the trusted advisor mix | Target life sciences consulting practices and strategy teams |
| 8 | Legal Services | Relevant for deal structuring, licensing, IP, and partnerships | Target life sciences legal counsel and transaction teams |
| 9 | Information Technology & Services | Useful for digital health, clinical operations, and R&D enablement solutions | Target software and data vendors serving life sciences |
| 10 | Biotech / Pharma adjacent services | Supports CRO, CDMO, and specialist service buying behavior | Target outsourcing and vendor-management decision makers |
6. Estimated Attendance
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | Not publicly confirmed | Confirmed unavailable | Official event page does not publish headcount | Use attendance as a qualitative rather than quantitative planning metric |
| Exhibitor count | Not publicly confirmed | Confirmed unavailable | Official event text provided does not include exhibitor numbers | Event appears more partner/networking-led than traditional large exhibition format |
| Buyer count | Not publicly confirmed | Confirmed unavailable | Official page references CEOs, investors, big pharma, and commercial leaders | Buyer concentration is likely high even without a published count |
| Speaker count | 8 named past speakers in the provided source text | Confirmed historical evidence | Official page excerpt | Past speakers are evidence of senior audience quality, not current-year attendance |
| Historical attendance | Not publicly confirmed | Confirmed unavailable | Organizer did not provide a number in the supplied official text | Attendance figure not publicly confirmed by the organizer |
7. Key Focus Areas and Buyer Engagement
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Partnering / BD&L | Find strategic collaborators, licensors, and co-development opportunities | Intro meetings, partnering platform demos, and structured matchmaking | Partnership software, deal intelligence, advisory services |
| Fundraising / Investment | Meet investors and present portfolio or pipeline opportunities | Investor meetings and pitch sessions | Investor relations, diligence support, fundraising advisory |
| Innovation Scouting | Identify external technologies and early-stage assets | Targeted meetings with biotech founders and platform companies | Scouting tools, innovation management, research intelligence |
| Clinical Development | Scale trials and improve operational execution | Supplier meetings with CROs, analytics firms, and clinical tech vendors | CRO services, eClinical software, site support |
| Commercialization | Prepare for market entry and launch strategy | Engage commercial leaders and advisors | Market access, pricing, commercialization consulting |
| Academic Translation | Move discoveries from lab to company or partner | Meet tech transfer offices and research leaders | Tech transfer support, grant services, research platforms |
Lead Quality Assessment
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | Very High | The event is explicitly positioned around biotech CEOs, investors, big pharma, commercial leaders, and trusted advisors. |
| Decision-maker availability | Very High | Executive-level attendees are the stated target audience, making it strong for high-level outreach. |
| Data collection potential | High | Good for collecting executive contacts, partnership interest signals, and account intelligence. |
| Apollo targeting potential | Very High | Clear industry, title, geography, and seniority filters can be built around the audience. |
| Geographic targeting potential | High | Boston and broader US life sciences hubs are strong target geographies, with international extension. |
| Best outreach approach | High-touch ABM | Use executive personalization, partnering-focused messaging, and pre-event meeting requests. |
| Overall lead quality | Very High | Excellent for life sciences buyer profiling, attendee list sales, sponsorship targeting, and strategic prospecting. |
| Best use case | B2B attendee list building and executive account targeting | Most valuable for companies selling into biotech, pharma, investor, CRO, and innovation-led organizations. |
| Limitations / risks | Medium | No public current-year attendee list or attendance count was provided in the official source text. |
Apollo.io Targeting Recommendation
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Biotechnology; Pharmaceuticals; Venture Capital & Private Equity; Hospital & Health Care; Research; Information Technology & Services; Management Consulting; Legal Services | Focus on companies most likely to buy, partner, invest, or advise at the event |
| Departments | Executive; Business Development; Corporate Development; Innovation; R&D; Clinical Development; Investor Relations; Partnerships | Reach the functions most relevant to partnering and strategic vendor buying |
| Seniority | C-Level; VP; Director; Head; Partner; Principal | Prioritize decision-makers and high-influence buyers |
| Job titles | CEO, Founder, Chief Business Officer, VP Business Development, Corporate Development Director, Head of Innovation, Alliance Management Director, Investor, Partner, Principal, Clinical Development VP | Target titles most likely to attend a partnering-heavy life sciences congress |
| Geography | United States; Northeast US; Massachusetts; Greater Boston; Cambridge; New York; New Jersey; California; North Carolina | Prioritize life sciences clusters with strong conference participation and buying power |
| Employee size | 11–50; 51–200; 201–500; 501–1,000; 1,001+ | Cover early-stage biotech through large pharma and investor-backed organizations |
| Keywords | biotech, pharma, therapeutics, drug discovery, partnering, licensing, clinical development, alliance, innovation, venture, life sciences | Refine lead searches to event-relevant commercial intent |
| Company type | Private companies, public companies, VC-backed firms, academic institutions, government innovation offices | Match the event’s mix of corporate, investor, and ecosystem participants |
| Revenue range | Relevant for established pharma and services firms; use selectively where available | Useful for prioritizing larger buyers with budget for services and partnerships |
| Technologies | Clinical trial software, R&D software, data analytics, market intelligence, partnering platforms, CRM | Identify buyers of enabling technology and workflow solutions |
Suggested Apollo Search Logic: (biotech OR pharmaceuticals OR life sciences OR therapeutics) AND (CEO OR founder OR “business development” OR “corporate development” OR innovation OR alliance OR investor OR partner) AND (Massachusetts OR Boston OR Cambridge OR United States).
Client Fit Review Required
Please share the client website or product/service details. I will review the client offering and identify the highest-fit buyer companies, Apollo industries, seniority levels, departments, and job titles from this event.
Sources & Verification Notes
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| Informa Connect – BioPharm America / LSX USA event page | Official organizer / event website | Event branding, merger with LSX USA, venue, Boston location, Congress dates, forum date, audience positioning, and senior audience description | Very High |
| Informa Connect | Organizer website | Organizer identity and event ownership context | Very High |
| Hynes Convention Center / Massachusetts Convention Center Authority | Venue website | Venue identity and Boston convention center context | High |
| Official event page text supplied by user | Primary source excerpt | Past speaker organizations, event format, and senior audience description | Very High |
| Official event page registration and content references | Official event content | Program timing, merger statement, and attendee profile cues | Very High |
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to LSX Congress USA — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds